Results 251 to 260 of about 32,363 (292)

A Pragmatic Trial Evaluating the Impact of the Anumana Clinical Decision Support Tool for Guideline-Directed Management of Heart Failure (ACT-HF): Clinical trial design and methods. [PDF]

Am Heart J Plus
Lopez-Jimenez F, Alger HM, Hackett SP, Gundurao V, Mehta K, Jain P, Kumar-M P, Padhye C, Puranik A, Vassor K, Ravi SK, Barry B, Chatterjee R, Chow C, Dolor R, Greene SJ, Lin G, Rushlow D, Stampehl M, Zhu X, Awasthi S.   +20 more
europepmc   +1 more source

Frequency & Predictors of Depression in Patients of Chronic Heart Failure with Reduced Ejection Fraction (HFrEF)

A B M Shafiuzzaman, Abdul Wadud Chowdhury, Md Gaffar Amin, Kazi N. Islam, ATM Mahfuzul Hoque, Isha Abdullah Ali, Basudev Kumar Kashyapi   +6 more
openalex   +2 more sources

LDL cholesterol and clinical outcomes in heart failure with reduced ejection fraction a competing risk analysis. [PDF]

Sci Rep
Wang Q, Liu Z, Zhou W, Wu G, Hu K, Su H, Yan J, Chen K.   +7 more
europepmc   +1 more source

A Multicenter, Randomized, Double-blind, Double-dummy, Parallel Group, Active-controlled, Forced-titration, 12-week Comparison of Combined Angiotensin-neprilysin Inhibition With Sacubitril and Valsartan Versus Enalapril on Changes in Central Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF)

Novartis
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

[Pharmacotherapy in HFrEF].

Deutsche medizinische Wochenschrift (1946), 2021
Since publication of the European Society guidelines for the diagnosis and treatment of acute and chronic heart failure in 2016, numerous studies provided new evidence how to further optimize heart failure therapy.Besides recent device-based therapeutic options, promising new drug developments give a glimmer of hope that the prognosis of this ...
Gülmisal, Güder, Stefan, Frantz
openaire   +1 more source

HFrEF phenotyping in real life

European Heart Journal, 2023
Abstract Background In May 2021 an HFA position paper[1] by Rosano GMC et al. classified patients with heart failure with reduced ejection fraction (HFrEF) into 11 phenotypes based on blood pressure, heart rate, renal function, potassium level and rhythm and assigned them to different prescription ...
A Weidenhammer, S Prausmueller, N Panagiotides, H Arfsten, G Heitzinger, G Spinka, A Barkhudaryan, P Bartko, M Huelsmann, N Pavo   +9 more
openaire   +1 more source

Metabolomic Profile in HFpEF vs HFrEF Patients

Journal of Cardiac Failure, 2020
Heart failure with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF) are associated with metabolic derangements, which may have different pathophysiological implications.In new-onset HFpEF (EF of ≥50%, n = 46) and HFrEF (EF of
Camilla Hage, Lars Löfgren, Filippos Michopoulos, Ralph nilsson, Pia Davidsson, Chanchal Kumar, Mattias Ekström, Maria J. Eriksson, Patrik Lyngå, Bengt Persson, Hakan Wallén, Li Ming Gan, Hans Persson, Cecilia Linde   +13 more
openaire   +2 more sources

Skeletal muscle alterations in HFrEF vs. HFpEF

Current Heart Failure Reports, 2017
Severe exercise intolerance and early fatigue are hallmarks of heart failure patients either with a reduced (HFrEF) or a still preserved (HFpEF) ejection fraction. This review, therefore, will provide a contemporary summary of the alterations currently known to occur in the skeletal muscles of both HFrEF and HFpEF, and provide some further directions ...
Volker, Adams, Axel, Linke, Ephraim, Winzer   +2 more
openaire   +2 more sources